Susceptibility-Diffusion Mismatch Predicts Thrombolytic Outcomes: A Retrospective Cohort Study

References

1. 1.↵
   2. Hacke W,
   3. Kaste M,
   4. Bluhmki E, et al

   . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Bivard A,
   3. Spratt N,
   4. Levi CR, et al

   . Acute stroke thrombolysis: time to dispense with the clock and move to tissue-based decision making? Expert Rev Cardiovasc Ther 2011;9:451–61

   CrossRefPubMed
3. 3.↵
   2. Grandin CB,
   3. Duprez TP,
   4. Smith AM, et al

   . Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361–70

   CrossRefPubMed
4. 4.↵
   2. Heiss WD

   . The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke: the Johann Jacob Wepfer award 2011. Cerebrovasc Dis 2011;32:307–20

   CrossRefPubMed
5. 5.↵
   2. Sobesky J

   . Refining the mismatch concept in acute stroke: lessons learned from PET and MRI. J Cereb Blood Flow Metab 2012;32:1416–25

   CrossRefPubMed
6. 6.↵
   2. Wang M,
   3. Dai Y,
   4. Han Y, et al

   . Susceptibility weighted imaging in detecting hemorrhage in acute cervical spinal cord injury. Magn Reson Imaging 2011;29:365–73

   CrossRefPubMed
7. 7.↵
   2. Haacke EM,
   3. Xu Y,
   4. Cheng YC, et al

   . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18

   CrossRefPubMedWeb of Science
8. 8.↵
   2. An H,
   3. Lin W

   . Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 2000;20:1225–36

   PubMedWeb of Science
9. 9.↵
   2. Hermier M,
   3. Nighoghossian N,
   4. Derex L, et al

   . Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator. J Cereb Blood Flow Metab 2003;23:1362–70

   CrossRefPubMed
10. 10.↵
    2. Lee JM,
    3. Vo KD,
    4. An H, et al

    . Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003;53:227–32

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Heiss WD

    . Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000;20:1276–93

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Powers WJ

    . Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991;29:231–40

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Robertson CA,
    3. McCabe C,
    4. Gallagher L, et al

    . Stroke penumbra defined by an MRI-based oxygen challenge technique. 2. Validation based on the consequences of reperfusion. J Cereb Blood Flow Metab 2011;31:1788–98

    CrossRefPubMed
14. 14.↵
    2. Santosh C,
    3. Brennan D,
    4. McCabe C, et al

    . Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab 2008;28:1742–53

    CrossRefPubMed
15. 15.↵
    2. Hermier M,
    3. Nighoghossian N,
    4. Derex L, et al

    . Hypointense leptomeningeal vessels at T2*-weighted MRI in acute ischemic stroke. Neurology 2005;65:652–53

    CrossRef
16. 16.↵
    2. Davis SM,
    3. Donnan GA,
    4. Parsons MW, et al

    . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Jauch EC,
    3. Saver JL,
    4. Adams HP Jr., et al

    . Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870–947

    Abstract/FREE Full Text
18. 18.↵
    2. Cappellari M,
    3. Bovi P,
    4. Moretto G, et al

    . The THRombolysis and STatins (THRaST) study. Neurology 2013;80:655–61

    CrossRef
19. 19.↵
    2. Olivot JM,
    3. Mlynash M,
    4. Thijs VN, et al

    . Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 2009;40:1692–97

    Abstract/FREE Full Text
20. 20.↵
    2. Kakuda W,
    3. Lansberg MG,
    4. Thijs VN, et al

    . Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008;28:887–91

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Olivot JM,
    3. Mlynash M,
    4. Thijs VN, et al

    . Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469–75

    Abstract/FREE Full Text
22. 22.↵
    2. Lansberg MG,
    3. Straka M,
    4. Kemp S, et al

    . MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860–67

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Straka M,
    3. Albers GW,
    4. Bammer R

    . Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010;32:1024–37

    CrossRefPubMed
24. 24.↵
    2. Fiebach JB,
    3. Al-Rawi Y,
    4. Wintermark M, et al

    . Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase. Stroke 2012;43:1561–66

    Abstract/FREE Full Text
25. 25.↵
    2. Jensen-Kondering U,
    3. Böhm R

    . Asymmetrically hypointense veins on T2*w imaging and susceptibility-weighted imaging in ischemic stroke. World J Radiol 2013;5:156–65

    PubMed
26. 26.↵
    2. Rosso C,
    3. Belleville M,
    4. Pires C, et al

    . Clinical usefulness of the visibility of the transcerebral veins at 3T on T2*-weighted sequence in acute stroke patients. Eur J Radiol 2012;81:1282–87

    CrossRefPubMed
27. 27.↵
    2. Kao HW,
    3. Tsai FY,
    4. Hasso AN

    . Predicting stroke evolution: comparison of susceptibility-weighted MR imaging with MR perfusion. Eur Radiol 2012;22:1397–403

    CrossRefPubMed
28. 28.↵
    2. Lansberg MG,
    3. Thijs VN,
    4. Bammer R, et al

    . The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 2008;39:2491–96

    Abstract/FREE Full Text
29. 29.↵
    2. Parsons MW,
    3. Christensen S,
    4. McElduff P, et al

    . Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214–25

    CrossRefPubMed
30. 30.↵
    2. Albers GW,
    3. Thijs VN,
    4. Wechsler L, et al

    . Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Sheerin F

    . The imaging of the cerebral venous sinuses. Semin Ultrasound CT MR 2009;30:525–58

    CrossRefPubMed
32. 32.↵
    2. Leach JL,
    3. Fortuna RB,
    4. Jones BV, et al

    . Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006;26(suppl 1):S19–41, discussion S42–43

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Oran I,
    3. Memis A,
    4. Sener RN, et al

    . The so-called transcerebral veins: appearance in three different cases. Comput Med Imaging Graph 1999;23:127–31

    CrossRefPubMed
34. 34.↵
    2. Hakim AM,
    3. Evans AC,
    4. Berger L, et al

    . The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 1989;9:523–34

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Wise RJ,
    3. Bernardi S,
    4. Frackowiak RS, et al

    . Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain 1983;106(pt 1):197–222

    Abstract/FREE Full Text
36. 36.↵
    2. Kidwell CS,
    3. Alger JR,
    4. Saver JL

    . Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729–35

    Abstract/FREE Full Text
37. 37.↵
    2. Marckmann P,
    3. Skov L,
    4. Rossen K, et al

    . Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359–62

    Abstract/FREE Full Text